Cargando…

Utility of Tissue Inhibitor Metalloproteinase-1 and Osteopontin as Prospective Biomarkers of Early Cardiovascular Complications in Type 2 Diabetes

AIM: This work investigated associations between tissue inhibitor metalloproteinase-1 and diabetic cardiovascular diseases in type 2 diabetic patients; also it investigated the role of osteopontin in the diagnosis of type 2 cardiovascular diabetes complications. SUBJECTS AND METHODS: These were exam...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Din, Doaa Samir Salah, Amin, Ahmed Ibrahim, Egiza, Ahmed Osman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Republic of Macedonia 2018
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839439/ https://www.ncbi.nlm.nih.gov/pubmed/29531595 http://dx.doi.org/10.3889/oamjms.2018.081

Ejemplares similares

Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases Ratio: A Biomarker of Bone Resorption in Geriatric Osteoporosis?
por: Bektan Kanat, Bahar, et al.
Publicado: (2023)

Osteopontin in Cardiovascular Diseases
por: Shirakawa, Kohsuke, et al.
Publicado: (2021)

Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma
por: Lee, Hyun Jung, et al.
Publicado: (2014)

Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial
por: Abdalrhim, Ahmed D., et al.
Publicado: (2016)

The Role of Osteopontin in the Pathogenesis and Complications of Type 1 Diabetes Mellitus in Children
por: Talat, Mohamed A., et al.
Publicado: (2016)

Osteopontin for Early Detection of Microvascular and Macrovascular Type 1 Diabetic Complication
por: El Dayem, Soha M. Abd, et al.
Publicado: (2019)

The involvement of osteopontin and matrix metalloproteinase- 9 in the migration of endometrial epithelial cells in patients with endometriosis
por: Yang, Mei, et al.
Publicado: (2015)

Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2010)

Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer
por: Sun, Ying, et al.
Publicado: (2015)

Osteopontin Promotes Expression of Matrix Metalloproteinase 13 through NF-κB Signaling in Osteoarthritis
por: Li, Yusheng, et al.
Publicado: (2016)

Expression of osteopontin, matrix metalloproteinase-2 and -9 proteins in vascular instability in brain arteriovenous malformation
por: Anbarasen, Lalita, et al.
Publicado: (2019)

Exercise-induced responses in matrix metalloproteinases and osteopontin are not moderated by exercise format in males with overweight or obesity
por: Raman, Aaron, et al.
Publicado: (2023)

Osteopontin as a biomarker for osteosarcoma therapy and prognosis
por: Han, Xingwen, et al.
Publicado: (2019)

Osteopontin -- a promising biomarker for cancer therapy
por: Wei, Ran, et al.
Publicado: (2017)

Osteopontin is a biomarker for early autoimmune uveoretinitis
por: Kim, Jeongtae, et al.
Publicado: (2021)

Osteopontin as a Biomarker in Chronic Kidney Disease
por: Sinha, Satyesh K., et al.
Publicado: (2023)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2020)

Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
por: Peeters, Stijn A, et al.
Publicado: (2015)

Role of Osteopontin in Psoriasis: An Immunohistochemical Study
por: Abdel-Mawla, M Yousry, et al.
Publicado: (2016)

Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer
por: Ławicki, Sławomir, et al.
Publicado: (2016)

Determinant of Osteopontin Levels in Microvascular Complications in Patients with Diabetes
por: Nawaz, Shaik Sarfaraz, et al.
Publicado: (2022)

Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage
por: Jürets, Alexander, et al.
Publicado: (2016)

Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
por: Peeters, Stijn A, et al.
Publicado: (2015)

Osteopontin as Candidate Biomarker of Coronary Disease despite Low Cardiovascular Risk: Insights from CAPIRE Study
por: Carbone, Federico, et al.
Publicado: (2022)

Utility of Plasma Osteopontin Levels in Management of Community-Acquired Pneumonia
por: Chang, Jer-Hwa, et al.
Publicado: (2016)

Osteopontin - a biomarker for organ damage in paediatric lupus?
por: Briggs, Tracy A
Publicado: (2013)

Salivary Osteopontin as a Potential Biomarker for Oral Mucositis
por: Gebri, Enikő, et al.
Publicado: (2021)

Osteopontin May Improve Postinjury Muscle Repair Via Matrix Metalloproteinases And tgf-β Activation in Regular Exercise
por: Wang, Yuchong, et al.
Publicado: (2023)

Urinary metalloproteinases and tissue inhibitors of metalloproteinases as potential early biomarkers for renal fibrosis in children with nephrotic syndrome
por: Bieniaś, Beata, et al.
Publicado: (2018)

Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer
por: Zhang, Yangyu, et al.
Publicado: (2020)

Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis?
por: Hoffmann, Ursula, et al.
Publicado: (2009)

Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma
por: Fouad, Shawky Abdelhamid, et al.
Publicado: (2015)

Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future
por: Omran, Farah, et al.
Publicado: (2022)

Omouma: a prospective mother and child cohort aiming to identify early biomarkers of pregnancy complications in women living in Qatar
por: Kumar, Manoj, et al.
Publicado: (2021)

Serum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular Carcinoma
por: Hodeib, Hossam, et al.
Publicado: (2017)

Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms
por: Kidess, Evelyn, et al.
Publicado: (2023)

Selected Metal Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases as Potential Biomarkers for Tubulointerstitial Fibrosis in Children with Unilateral Hydronephrosis
por: Bieniaś, Beata, et al.
Publicado: (2020)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

The effect of osteopontin and osteopontin-derived peptides on preterm brain injury
por: Albertsson, Anna-Maj, et al.
Publicado: (2014)

The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis
por: Lavi, Hadas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_74kj7ij371n2dmeeqaopltrhtf